Professor Rod Dunbar: Ledger

Stories naming Professor Rod Dunbar. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Role	Organisation	Sources
Professor	University of Auckland	Brandon Capital portfolio

2 deals

Over $15m invested in world-leading cancer immunotherapy

Auckland University spinout TamoRx has secured NZ$15.25 million to develop a new cancer immunotherapy, in a round led by Brandon Capital alongside the university's Inventors' Fund, with a Callaghan Innovation grant included.

Brandon Capital portfolio Mon 6 Jun 2022 Brandon BioCatalyst Mana Communications Uniservices University of Auckland Brandon Capital Callaghan Innovation University of Auckland Inventors' Fund Duncan Mackintosh Evelyn Body Professor Rod Dunbar

Professor Rod Dunbar

Roles

Coverage

Over $15m invested in world-leading cancer immunotherapy